The highly anticipated new Retatrutide 20mg device is now entering the market in the UK. As of now, access is limited and primarily through specialist healthcare providers participating in clinical trials . Despite a full, general commercial launch date remains unspecified , initial reports that those eligible may be permitted to obtain the treatme